Omega Ophthalmics
Cataract surgery is the single most common procedure performed in the United States annually. Despite technological advancements in both surgical instrumentation and intraocular lens design, approximately 50% of patients are still unable to see well without glasses after surgery. Omega Ophthalmics has developed a new, proprietary lens that will increase the number of “glasses free” post-surgery patients to over 90% by reducing the variables during surgery, revolutionizing a market that has not seen positive, disruptive change in over sixty years. Since the global intraocular lens market has steadily grown and is currently projected to reach $4.3 billion by 2017, the Omega Gemini Refractive Capsule is well-positioned to become the new standard lens for cataract surgery. The Omega Gemini Refractive Capsule is an investigational device and is not approved for use in the United States.
Domain
omegaophthalmics.com
Country
United StatesIndustry
Augmented RealityEmployees
51-100
Last Funding
$0.3M
Founded
2012
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Omega Ophthalmics use?+
Omega Ophthalmics uses 19 technologies including Contact Form 7, Google Analytics, Google Tag Manager.
What industry is Omega Ophthalmics in?+
Omega Ophthalmics operates in the Augmented Reality industry.
Where is Omega Ophthalmics based?+
Omega Ophthalmics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026